[Company centredness in the rehabilitation system of the German Democratic Republic, GDR]. / Die Betriebszentrierung im Rehabilitationssystem der DDR.

This article describes major aspects of the rehabilitation system of the former German Democratic Republic, GDR. Based on presentation of the actors in the medical and occupational rehabilitation system, differences are pointed out in comparison to the notion of rehabilitation in the former Federal Republic of Germany, FRG. The article focuses on the system of rehabilitation after stroke, which is outlined with relevant scientific literature. The health and rehabilitation system of the GDR was company-centred. Patients in rehabilitation received comprehensive care and guidance, and especially the companies played an integrative part and adjusted the occupational activity of the patients in rehabilitation to their physical and mental abilities in order to avoid early retirement. On account of the political and social transformation process as well as transfer of the health and rehabilitation legislation of the old FRG, the company-centred rehabilitation system of the GDR was replaced, implementing West German rehabilitation structures in East Germany as well.

[Production of maedi-visna virus antigen for the immunodiffusion test and its use for field studies]. / Herstellung von Maedi-Visna-Virusantigen für den Immundiffusionstest und sein Einsatz für Felduntersuchungen.

Using the Maedi-Visna virus strain WLC1 (Weybridge) and different cell lines of sheep plexus chorioideus we were able to establish and improve a production procedure of MV-antigen for use in immunodiffusion assay. Our attention was focused mainly on the efficient virus multiplication in cell cultures and on standardisation of the procedure to find a method keeping the antigen loss as low as possible. Investigations with our antigen in 39 farms of 5 of the former districts in East Germany revealed a seropositive reagent rate between 0 and more than 60%, underlining the need for a complex diagnostic and eradication programme.

Application of microbiological cancer test to cattle infected with bovine leucosis virus.

A microbiological cancer test, previously verified in men and dogs using a clostridium strain (Clostridium butyricum CNRZ 528), was applied to cattle infected with bovine leucosis virus (BLV). An extended period of time was allowed to pass after infection with BLV, which had been checked up through specific serological and virological examinations. The cattle belonged to different age groups and stages of infection (with and without haematological alterations [preleukosis], with incipient tumour development [swelling of externally visible and palpable lymph nodes]). Controls included BLV-infected cows as well as test animals to which isotonic saline had been applied or healthy BLV-free cattle in which the clostridium strain had been used. The serological investigation was carried out in a blind test. 3 of 6 BLV-infected spore-treated heads of cattle responded positively to the cancer test, while the other 3 were negative. The 3 cows with positive cancer test were haematologically and serologically leucosis-positive animals with clinically detectable enlargement of lymph nodes. The 3 negative ones of this group, also serologically and haematologically leucosis-positive, were younger animals without signs of tumorous process. 3 spore-treated BLV-free cows and 2 BLV-infected animals, treated with isotonic saline, were cancer test-negative, as well. Finally, 4 BLV-infected and 2 BLV-free cattle, all of them without spore injection, were completely cancer test-negative. 1 cow of the BLV-infected group did not produce spore antibodies after spore treatment, while 1 cow of the BLV-free untreated control group developed spore antibodies.